INTERVIEW: Cambridge Cognition Leveraging its new COO

Cambridge Cognition Holdings plc (LON: COG) new COO Matthew Stork joins DirectorsTalk to talk about his move to the company. Matthew provides us with detail around his career, explains why he joined COG, how his past experience will be leveraged in his new role, how he has found the business so far and initial thoughts on growth drivers for the business.

Cambridge Cognition is a leading neuroscience technology company optimising the assessment of cognition for better brain health with scientifically validated digital health solutions. Its software enables gold standard research and efficient clinical trials, accelerating safe and effective treatment development and helping to improve patient outcomes in conditions affecting brain health.

For over 30 years, their technology has been at the forefront of scientific discovery, delivering value to research institutions, healthcare providers and pharmaceutical and biotechnology companies worldwide. From digital health tools to mobile applications for drug development, they provide best in class, interactive and innovative digital cognitive assessment technologies that capture meaningful, reliable data anytime, anywhere.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions

Cambridge Cognition Holdings

Cambridge Cognition investor webinar on 3 May 2023

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, will be announcing the Company’s preliminary financial results for the year ended 31 December 2022 on Wednesday 3 May 2023 and